Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
REALITY: Aliskiren in Essential Hypertension
NCT01060865Phase 4Terminated
- Sponsor
- Meir Medical Center
- Start
- Mar 2010
- Primary completion
- Oct 2011
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of aliskiren in essential hypertension, sponsored by Meir Medical Center. Started Mar 2010; status: terminated.
02
Drugs
aliskiren
03
Conditions
essential hypertension
Beyond the preview
Go deeper on NCT01060865.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01060865.